173 related articles for article (PubMed ID: 32767223)
21. The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma.
Kachare SD; Brinkley J; Wong JH; Vohra NA; Zervos EE; Fitzgerald TL
Ann Surg Oncol; 2014 Oct; 21(11):3377-85. PubMed ID: 25063010
[TBL] [Abstract][Full Text] [Related]
22. Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
Baum C; Weiss C; Gebhardt C; Utikal J; Marx A; Koenen W; Géraud C
Int J Cancer; 2017 Apr; 140(8):1907-1917. PubMed ID: 27935036
[TBL] [Abstract][Full Text] [Related]
23. Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis.
Nijhuis AAG; Santos Filho IDAO; Holtkamp LHJ; Uren RF; Thompson JF; Nieweg OE
Ann Surg Oncol; 2020 Feb; 27(2):561-568. PubMed ID: 31407174
[TBL] [Abstract][Full Text] [Related]
24. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a Brazilian nomogram to assess sentinel node biopsy positivity in melanoma.
Bertolli E; Calsavara VF; de Macedo MP; Pinto CAL; Duprat Neto JP
Tumori; 2021 Oct; 107(5):440-445. PubMed ID: 33143554
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of incomplete sentinel node biopsy procedures and sentinel node positivity rates as surgical quality-assurance parameters in melanoma patients.
Spillane AJ; Haydu LE; Lee NC; Uren RF; Stretch JR; Shannon KF; Quinn MJ; Saw RP; McCarthy WH; Thompson JF
Ann Surg Oncol; 2012 Nov; 19(12):3919-25. PubMed ID: 22644517
[TBL] [Abstract][Full Text] [Related]
27. The impact of immunohistochemistry on sentinel node biopsy for primary cutaneous malignant melanoma.
Ross GL; Shoaib T; Scott J; Camilleri IG; Gray HW; MacKie R; Soutar DS
Br J Plast Surg; 2003 Mar; 56(2):153-5. PubMed ID: 12791361
[TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II.
Fink AM; Holle-Robatsch S; Herzog N; Mirzaei S; Rappersberger K; Lilgenau N; Jurecka W; Steiner A
Melanoma Res; 2004 Apr; 14(2):141-5. PubMed ID: 15057045
[TBL] [Abstract][Full Text] [Related]
29. Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population.
Tsutsumida A; Furukawa H; Yamamoto Y; Horiuchi K; Yoshida T; Minakawa H; Fujii S; Murao N; Kuwahara H; Minamimoto T; Fujioka H; Sakamoto T; Honma T
Int J Clin Oncol; 2007 Aug; 12(4):245-9. PubMed ID: 17701001
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of intra-nodal naevi in sentinel node biopsies for malignant melanoma.
Smith OJ; Coelho JA; Trevatt AE; Ross GL
Eur J Surg Oncol; 2016 Sep; 42(9):1427-31. PubMed ID: 27262872
[TBL] [Abstract][Full Text] [Related]
31. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
Scheri RP; Essner R; Turner RR; Ye X; Morton DL
Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
[TBL] [Abstract][Full Text] [Related]
32. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
33. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
Morton DL; Cochran AJ; Thompson JF; Elashoff R; Essner R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ;
Ann Surg; 2005 Sep; 242(3):302-11; discussion 311-3. PubMed ID: 16135917
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study.
Moncrieff MD; Lo SN; Scolyer RA; Heaton MJ; Nobes JP; Snelling AP; Carr MJ; Nessim C; Wade R; Peach AH; Kisyova R; Mason J; Wilson ED; Nolan G; Pritchard Jones R; Sondak VK; Thompson JF; Zager JS
Ann Surg Oncol; 2022 Sep; 29(9):5937-5945. PubMed ID: 35562521
[TBL] [Abstract][Full Text] [Related]
35. Checkpoint blockade and BRAF/MEK therapy in the therapeutic setting improved the overall survival after sentinel node biopsy: A retrospective study comparing patients with primary care between 1998-2009 and 2010-2017.
Kretschmer L; Bernhard L; Leha A; Kromer C; Julius K; Schön MP; Schnabel V
Int J Cancer; 2023 Jul; 153(2):380-388. PubMed ID: 36789913
[TBL] [Abstract][Full Text] [Related]
36. Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study.
Rossi CR; Mocellin S; Campana LG; Borgognoni L; Sestini S; Giudice G; Caracò C; Cordova A; Solari N; Piazzalunga D; Carcoforo P; Quaglino P; Caliendo V; Ribero S;
Ann Surg Oncol; 2018 Jan; 25(1):271-279. PubMed ID: 29067603
[TBL] [Abstract][Full Text] [Related]
37. Utility of a 31-gene expression profile for predicting outcomes in patients with primary cutaneous melanoma referred for sentinel node biopsy.
Arnot SP; Han G; Fortino J; Han D; Fowler G; Vetto JT
Am J Surg; 2021 Jun; 221(6):1195-1199. PubMed ID: 33773750
[TBL] [Abstract][Full Text] [Related]
38. Sentinel node biopsy in thin and thick melanoma.
Mozzillo N; Pennacchioli E; Gandini S; Caracò C; Crispo A; Botti G; Lastoria S; Barberis M; Verrecchia F; Testori A
Ann Surg Oncol; 2013 Aug; 20(8):2780-6. PubMed ID: 23720068
[TBL] [Abstract][Full Text] [Related]
39. When should pelvic sentinel lymph nodes be harvested in patients with malignant melanoma?
Kaoutzanis C; Barabás A; Allan R; Hussain M; Powell B
J Plast Reconstr Aesthet Surg; 2012 Jan; 65(1):85-90. PubMed ID: 21940229
[TBL] [Abstract][Full Text] [Related]
40. [Sentinel node biopsy as a prognostic factor in cutaneous melanoma].
Avilés-Izquierdo JA; Lázaro-Ochaita P
Actas Dermosifiliogr; 2009; 100(6):486-92. PubMed ID: 19709553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
